Health System

Asking whether hydrocodone should be rescheduled is only the beginning.

A new government report found evidence of Veterans Affairs doctors at one California hospital renewing highly addictive narcotic painkillers for patients they had never seen.

Patients who quit taking their statins are frequently on 3-4 other meds as well, and drug interactions are amplifying their experience of muscle pain.

Reevaluation of RECORD trial data fails to uncover elevated cardiovascular risk.

When pharmacists manage drug therapy for physicians, diabetes patients see a significant improvement in key measures.

CMS' new rules for fees, mail order, and delivery of diabetes testing products have created big challenges for patients and the community pharmacists who used to deliver their supplies.

Prescribers treating obese and overweight patients with diabetes now have two new treatment options to consider.

In the wake of last year's fungal meningitis tragedy, the Specialty Sterile Pharmaceutical Society brings a new voice to an industry under fire.

Grass-roots successes achieved at the state and local levels support federal initiatives pursued by the national pharmacy organization.

Patients in rural settings can still receive personalized care from pharmacists. With tele consults, all they need is an internet connection and a laptop.

With obesity rates growing and diabetes diagnoses going up, healthcare providers are focusing on the need to treat GDM in both mother and unborn child.

How can an independent pharmacy survive in the face of competition from the mega-chains? Here's a clue.

When it comes to knowledge of medications and their actions, pharmacists have it way over most physicians. For the sake of the patient, you have to speak up, whether the doc likes it or not.

In disaster relief, inappropriate pharmaceutical donations and/or a disorganized receiving operation can mean that tons of medications go straight into the rubbish.

A small study of patients undergoing bariatric surgery suggests that weekly warfarin doses can change by as much as 20% postoperatively.

The bicameral legislation provides specific requirements for all stakeholders in the drug-distribution supply chain, including manufacturers, wholesalers, repackagers, and pharmacies.

CSL Behring's Kcentra is is currently the only 4-factor PCC available in the United States.

Use of both AACE and ADA/EASD guidelines can benefit physicians, pharmacists, and other healthcare practitioners.

Drug Topics’ legal compliance columnist named partner in Roetzel's Chicago office and head of the firm’s Drug and Pharmacy practice.

Product updates for pharmacists: New Rx, generic, and OTC

Technology-based messaging support for at-risk and diabetic patients is being tested in 17 communities across the country. Three of the participating programs have released their evaluations and conclusions.

A peek into a very special world.

The American Society of Health-System Pharmacists is backing FDA’s recommendation that hydrocodone combination products be reclassified as Schedule II drugs under the Controlled Substances Act.

Representatives of Boehringer Ingelheim reported the data at the 64th Annual Meeting of the American Association for the Study of Liver Diseases.

More than 10% of teens and young adults admit misusing a prescription painkiller or sedative, according to a study published in Pediatrics.

Costs related to antibiotics are the most important factors influencing hospital formulary decision-making, according to a new report.

The Children’s Hospital of Philadelphia recently became the first U.S. hospital to disallow most dietary supplements in its formulary.

Rude and disrespectful behavior including bullying and intimidation is a big problem in healthcare workplaces that erodes professional communication essential to patient safety, according to a recent study by the Institute for Safe Medication Practices.

Regardless of their income, employment status, and access to resources, patients want to support their health, and pharmacists can help them do it.

In the treatment of pulmonary embolism (PE) in North American patients, rivaroxaban (Xarelto) reduced length of hospital stay by 1 full day compared to conventional dual therapy, according to data presented at the American College of Emergency Physicians scientific assembly, October 14-17, in Seattle.